Eyeworld Daily News

2013 ASCRS•ASOA San Francisco Daily News Sunday

EyeWorld Today is the official daily of the ASCRS Symposium & Congress. Each issue provides comprehensive coverage editorial coverage of meeting presentations, events, and breaking news

Issue link: https://daily.eyeworld.org/i/124062

Contents of this Issue

Navigation

Page 80 of 87

Integrating new technology into a practice for optimal outcomes www.eyeworld.org 2013 ASCRS•ASOA San Francisco Show Daily Supplement This Show Daily supplement is sponsored by Alcon. WaveLight Refractive Suite: A game changer by George O. Waring IV, MD Offering a new generation of patients an advanced form of LASIK A s the economy begins to improve, consumers are showing renewed interest in refractive surgery procedures. LASIK vol- umes have increased, particularly in the target population of Generation Y or Millennials. These are patients who value a "no nonsense" approach. They want facts, they want speed, and they want results. The WaveLight* Refractive Suite (Alcon, Fort Worth, Texas) is particularly well suited to address these patients' requirements—it pairs the fastest commercially available excimer laser in the U.S., the EX500, with the fastest commercially available femtosecond laser, the FS200. EX500: Recovery times The WaveLight EX500 Laser has a repetition rate of 500 Hz, which continued on page 2 George O. Waring IV, MD " The WaveLight EX500 Laser delivers not only a great patient experience, but a surgeon's 'wow factor.' " This supplement was produced by EyeWorld and sponsored by Alcon. The doctors featured in this supplement received compensation from Alcon for their contributions to this supplement. Copyright 2013 ASCRS Ophthalmic Corporation. All rights reserved. The views expressed here do not necessarily reflect those of the editor, editorial board, or the publisher, and in no way imply endorsement by EyeWorld or ASCRS. The WaveLight EX500 Laser is part of an overall refractive suite that includes both the excimer and a femtosecond laser. Source: George O. Waring, IV, MD Please refer to pages 7 and 8 for important safety information about the Alcon products described in this supplement.

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld Daily News - 2013 ASCRS•ASOA San Francisco Daily News Sunday